Mercurius Beleggingsmaatschappij

Mercurius Beleggingsmaatschappij is a private Dutch investment firm that serves as a primary investment vehicle for the Van Herk Group, led by prominent investor Aat van Herk. The company is a significant player in the European life sciences landscape, known for taking substantial, long-term equity positions in biotechnology and pharmaceutical companies. Its portfolio has historically included major stakes in industry leaders such as BioNTech, Galapagos, and Pharming. Based in Rotterdam, Mercurius focuses on high-impact healthcare innovations and maintains a reputation for providing patient capital within the Benelux biotech ecosystem. The firm's investment strategy typically emphasizes platform technologies and companies with late-stage clinical development programs.